Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease

Digestive and Liver Disease - Tập 44 Số 8 - Trang 649-654 - 2012
Hiroyuki Hanai1, Takayuki Iida1, Ken Takeuchi1, Hajime Arai1, Osamu Arai1, Jinrou Abe1, Tatsuo Tanaka1, Yasuhiko Maruyama1, Kentaro Ikeya2, Ken Sugimoto3, Toshio Nakamura4, Kouichi Nakamura4, Fumitoshi Watanabe1
1Centre for Gastroenterology and Inflammatory Bowel Disease Research, Hamamatsu South Hospital, Hamamatsu, Japan
2Fujieda Municipal Hospital, Japan
3First Department of Medicine, Hamamatsu University, Japan
4Second Department of Surgery, Hamamatsu University, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

1998

Shanahan, 2002, Crohn's disease, Lancet, 359, 62, 10.1016/S0140-6736(02)07284-7

Podolsky, 2002, Inflammatory bowel disease, N Engl J Med, 347, 417, 10.1056/NEJMra020831

Sartor, 1997, Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases, Am J Gastroenterol, 92, 5S

Kozuch, 2008, Treatment of inflammatory bowel disease: a review of medical therapy, World J Gastroenterol, 14, 354, 10.3748/wjg.14.354

MacDermott, 2007, Refractory ulcerative colitis treatment, Gastroenterol Hepatol (NY), 3, 64

Aberra, 2005, Review article: monitoring immunomodulators in inflammatory bowel disease, Aliment Pharmacol Ther, 21, 307, 10.1111/j.1365-2036.2005.02343.x

Elion, 1989, The purine path to chemotherapy, Science, 244, 41, 10.1126/science.2649979

Sandborn, 1996, A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine and methotrexate, Am J Gastroenterol, 91, 423

Lennard, 1992, The clinical pharmacology of 6-mercaptopurine, Eur J Clin Pharmacol, 43, 329, 10.1007/BF02220605

Teml, 2007, Thiopurine treatment in inflammatory bowel disease, clinical pharmacology and implication of pharmacogenetically guided dosing, Clin Pharmacokinet, 46, 187, 10.2165/00003088-200746030-00001

Gisbert, 2007, Thiopurine methyltransferase activity in Spain: a study of 14545 patients, Dig Dis Sci, 52, 1262, 10.1007/s10620-006-9119-z

Yamamoto, 2009, Review article: diet and inflammatory bowel disease—epidemiology and treatment, Aliment Pharmacol Ther, 30, 99, 10.1111/j.1365-2036.2009.04035.x

Tragnone, 1995, Dietary habits as risk factors for inflammatory bowel disease, Eur J Gastroenterol Hepatol, 7, 47

Amre, 2007, Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children, Am J Gastroenterol, 102, 2016, 10.1111/j.1572-0241.2007.01411.x

Fukuda, 1995, Efficacy of nutritional therapy for active Crohn's disease, J Gastroenterol, 30, 83

Fernandez-Banares, 1994, Enteral nutrition as primary therapy in Crohn's disease, Gut, 35, S55, 10.1136/gut.35.1_Suppl.S55

O’Keefe, 1996, Nutrition and gastrointestinal disease, Scand J Gastroenterol (Suppl), 220, 52, 10.3109/00365529609094750

Tsujikawa, 2003, Enteral and parenteral nutrition therapy for Crohn's disease, Curr Pharm Des, 9, 323, 10.2174/1381612033391964

Dupont, 2008, Enteral nutrition in adult Crohn's disease: present status and perspectives, Mol Nutr Food Res, 52, 875, 10.1002/mnfr.200800093

Griffiths, 2005, Enteral nutrition in the management of Crohn's disease, J Parenter Enteral Nutr, 29, S108, 10.1177/01486071050290S4S108

Sakurai, 2002, Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas, J Parenter Enteral Nutr, 26, 98, 10.1177/014860710202600298

Furukawa, 1997, Enteral nutrition and total parenteral nutrition in Crohn's disease: factors influencing induction of remission, Gastroenterol Jpn, 94, 813

Takagi, 2006, Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn's disease: a randomized-controlled trial, Aliment Pharmacol Ther, 24, 1333, 10.1111/j.1365-2036.2006.03120.x

Hanai, 2010, Thiopurine maintenance therapy for ulcerative colitis: the clinical significance of monitoring 6-thioguanine nucleotide, Inflamm Bowel Dis, 16, 1376, 10.1002/ibd.21190

Satsangi, 2006, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, 55, 749, 10.1136/gut.2005.082909

Dubinsky, 2000, Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease, Gastroenterology, 118, 705, 10.1016/S0016-5085(00)70140-5

McLeod, 1994, Thiopurine methyltransferase activity in American white subjects and black subjects, Clin Pharmacol Ther, 55, 15, 10.1038/clpt.1994.4

Alastair, 2011, Nutrition in inflammatory bowel disease, JPEN J Parenter Enteral Nutr, 35, 571, 10.1177/0148607111413599

Day, 2008, Systemic review: nutritional therapy in paediatric Crohn's disease, Aliment Pharmacol Ther, 27, 293, 10.1111/j.1365-2036.2007.03578.x

Wilschanski, 1996, Supplementary enteral nutrition maintains remission in paediatric Crohn's disease, Gut, 38, 543, 10.1136/gut.38.4.543

Riordan, 1993, Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial, Lancet, 342, 1131, 10.1016/0140-6736(93)92121-9

Lochs, 2006, ESPEN Guidelines on Enteral Nutrition, Clin Nutr, 25, 260, 10.1016/j.clnu.2006.01.007

Fell, 2000, Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease, Aliment Pharmacol Ther, 14, 281, 10.1046/j.1365-2036.2000.00707.x

Yamamoto, 2005, Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings, Inflamm Bowel Dis, 11, 580, 10.1097/01.MIB.0000161307.58327.96

Rutgeerts, 2007, Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?, Gut, 56, 453, 10.1136/gut.2005.088732